Superior Colliculus Activity in Parkinson Disease: a Potential Marker?

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

October 7, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 19, 2018

Conditions
Parkinson's Disease
Interventions
OTHER

fMRI

The investigators will use a non invasive fMRI technique centred on the superior colliculus during the presentation of flickered check-boards with varying contrast (1, 3, 5 and 9 %).

OTHER

Ophthalmologic evaluation

The aim of this experiment is the evaluate the functional state of a visual structure. Therefore, with this ophthalmologic test, the investigators will control if the participant does not present major visual deficits. This examination will evaluate the visual acuity and the visual field. A funduscopic examination will also be performed to check the retina.

OTHER

visual psychophysics test

This test will allow to control the sensitivity of the participant to our contrast. The participant will be asked to look at screen on which three static check-boards will be presented. The participant will have to choose the two check-boards with the closest contrast.

Trial Locations (3)

38000

CHU de Grenoble, Grenoble

Grenoble Institute of Neurosciences, Grenoble

IRMAGE, Grenoble

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02488395 - Superior Colliculus Activity in Parkinson Disease: a Potential Marker? | Biotech Hunter | Biotech Hunter